Magnesium intake (mg/day) | Serum vitamin D level (ng/ml) | Pfor trend | ||||
---|---|---|---|---|---|---|
<20 | 20 to 31 | 32 to 39 | ≥40 | |||
Total mortality | ||||||
Total | Cases | 1,274 | 1,547 | 558 | 324 | Â |
HR (95% CI) | 1.00 | 0.83 (0.74 to 0.94) | 0.80 (0.69 to 0.93) | 0.79 (0.66 to 0.93) | <0.01 | |
<264 | Cases | 848 | 786 | 249 | 143 | Â |
HR (95% CI) | 1.00 | 0.89 (0.74 to 1.08) | 0.87 (0.69 to 1.08) | 0.87 (0.64 to 1.20) | 0.23 | |
≥264 | Cases | 426 | 761 | 309 | 181 |  |
HR (95% CI) | 1.00 | 0.77 (0.64 to 0.92) | 0.73 (0.58 to 0.93) | 0.70 (0.57 to 0.88) | <0.01 | |
P for interaction | Â | Â | Â | Â | 0.96 | |
Cardiovascular mortality | ||||||
Total | Cases | 574 | 656 | 253 | 132 | Â |
HR (95% CI) | 1.00 | 0.73 (0.62 to 0.86) | 0.77 (0.61 to 0.99) | 0.73 (0.56 to 0.97) | 0.04 | |
<264 | Cases | 386 | 346 | 112 | 57 | Â |
HR (95% CI) | 1.00 | 0.83 (0.66 to 1.04) | 0.88 (0.61 to 1.28) | 0.91 (0.61 to 1.35) | 0.45 | |
≥264 | Cases | 188 | 310 | 141 | 75 |  |
HR (95% CI) | 1.00 | 0.59 (0.44 to 0.80) | 0.65 (0.44 to 0.95) | 0.57 (0.38 to 0.87) | <0.05 | |
P for interaction | Â | Â | Â | Â | 0.03 | |
Colorectal cancer mortality | ||||||
Total | Cases | 32 | 34 | 12 | 8 | Â |
HR (95% CI) | 1.00 | 0.84 (0.36 to 2.00) | 0.80 (0.31 to 2.05) | 0.50 (0.15 to 1.73) | 0.31 | |
<264 | Cases | 19 | 17 | 3 | 3 | Â |
HR (95% CI) | 1.00 | 1.17 (0.39 to 3.56) | 0.79 (0.17 to 3.75) | 0.85 (0.17 to 4.12) | 0.73 | |
≥264 | Cases | 13 | 17 | 9 | 5 |  |
HR (95% CI) | 1.00 | 0.55 (0.16 to 1.85) | 0.67 (0.17 to 2.64) | 0.28 (0.03 to 2.25) | 0.29 | |
P for interaction | Â | Â | Â | Â | 0.15 |